A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine. [electronic resource]
Producer: 20091007Description: 217-25 p. digitalISSN:- 1460-2377
- Adjuvants, Immunologic -- administration & dosage
- Animals
- Cell Proliferation -- drug effects
- Cytotoxicity, Immunologic -- drug effects
- Herpes Simplex -- immunology
- Herpesvirus 1, Human -- immunology
- Hypersensitivity, Delayed -- prevention & control
- Immunity, Cellular -- drug effects
- Immunization, Secondary
- Immunoglobulin G -- blood
- Mice
- Mice, Inbred BALB C
- Naloxone -- administration & dosage
- Narcotic Antagonists -- administration & dosage
- T-Lymphocytes, Cytotoxic -- cytology
- Th1 Cells -- immunology
- Vaccines, DNA -- administration & dosage
- Viral Envelope Proteins -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.